Zai Lab (NASDAQ:ZLAB) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.54) by 14.81 percent. This is a 2.22 percent decrease over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $99.611 million which missed the analyst consensus estimate of $108.450 million by 8.15 percent. This is a 6.46 percent decrease over sales of $106.487 million the same period last year.